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Introduction: The aim of this study was to investigate the diagnos-
tic value of percutaneous computed tomography (CT)-guided coax-
ial transthoracic needle biopsy (TNB) for small pulmonary lesions
(3 cm) with persistent ground-glass opacity (GGO).
Methods: From January 2004 to February 2010, consecutive pa-
tients with persistent small GGO lesions (3 cm) who underwent
CT-guided TNB were analyzed. The pathologic results of CT-
guided TNB were compared with final diagnoses, and the GGO
percentage on CT was correlated with the stromal invasion in
surgical pathology.
Results:We performed CT-guided TNB on 1612 patients during the
study period. Among them, 55 patients had persistent small GGO
lesions (size range 0.5–3.0 cm; 1.72  0.73 cm), 47 were diagnosed
with lung adenocarcinomas, and 8 with benign nonspecific lesions.
Minor procedure-related complications occurred in 26 patients
(47.3%) with small pneumothorax and 11 patients (20.0%) with
self-limited mild hemoptysis. The final diagnoses of the 43 patients
receiving lobectomy were invasive adenocarcinoma (n  23), pure
bronchioloalveolar carcinoma (n  19), and mucosa-associated
lymphoid tissue lymphoma (n  1). The diagnostic accuracy was
93.0% (40/43) using CT-guided TNB. Pure GGO lesions had a
higher incidence of pure bronchioloalveolar carcinoma than GGO-
dominant lesions (70.0% versus 21.7%; p  0.004). Compared with
surgical pathology, stromal invasion was underestimated in 43.5%
(10/23) of the TNB specimens, especially in pure GGO lesions
(83%, 5/6). In logistic regression analysis, the GGO percentage
correlated inversely with stromal tumor invasion (p  0.0028).
Conclusions: CT-guided coaxial TNB is a safe and useful method
for diagnosing small (3 cm) persistent GGO lesions. Stromal
invasion may be underestimated by TNB in GGO lesions.
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With the advent of low-dose screening computed tomog-raphy (CT), small lung cancers are being detected in
increasing numbers.1 Many of these CT-detected small lung
nodules are indeterminate, including lesions with focal
ground-glass opacity (GGO). GGO refers to an area of
increased lung attenuation without obscuration of underlying
vessels on thin-section CT.2 Focal GGO can be due to
variable etiologies, such as well-differentiated adenocarci-
noma, nodular fibrosis, bronchioloalveolar carcinoma (BAC),
atypical adenomatous hyperplasia, focal scar, granuloma, and
lymphoproliferative disease.3–8 It has been reported that 75%
of persistent GGO nodules are attributable to BAC or ade-
nocarcinoma with a predominant BAC component.9 It has
also been shown that the greater the portion of GGO, the
lower the frequency of nodal involvement and better prog-
nosis in lung adenocarcinoma.10–14 Limited thoracoscopic
resection may be sufficient for pure GGO lesions because of
a low probability of nodal involvement and local recur-
rence.7,15 Although it has been reported that the morphologic
classification is helpful to differentiate malignant GGO le-
sions from benign conditions,6 it is generally considered very
difficult based on CT findings alone.9 Therefore, periodic
follow-up to assess interval changes or surgical resection is
necessary for the management of a persistent GGO lesion.
Percutaneous CT-guided fine needle aspiration (FNA) has
been reported to be useful for peripheral small lung cancers
with an overall diagnostic yield of 51.2% for GGO-dominant
lesions and 75.6% for solid lesions.16 However, the low
diagnostic accuracy of using FNA to diagnose GGO-domi-
nant lesions means this method is not clinically practical. A
diagnostic accuracy of 91% using single-shot core biopsy for
peripherally located GGO lesions has been demonstrated.17
CT-fluoroscopy-guided FNA for persistent GGO lesions has
shown an accuracy of 82%.18 Limited surgical excision has
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also been an advocated method for diagnosing indeterminate
GGO lesions;7,15 however, this may be difficult in patients
with high comorbidities and poor lung function. The value of
the coaxial technique for CT-guided core biopsy has been
demonstrated with a higher accuracy than using core biopsy
alone.19–22 Therefore, investigating the role of percutaneous
CT-guided coaxial transthoracic needle biopsy (TNB) for
pulmonary GGO lesions is warranted. The purpose of this
study was to investigate the value of performing preoperative
percutaneous CT-guided core biopsies in patients with small
pulmonary GGO lesions using a coaxial technique.
MATERIALS AND METHODS
Patient Enrollment and Biopsy Procedure
Consecutive patients with persistent pulmonary GGO
lesions (50% GGO percentage in volume) smaller than or
equal to 3 cm who received percutaneous CT-guided lung
biopsies between January 2004 and February 2010 at Na-
tional Taiwan University Hospital were enrolled in this study.
The final histologic results of the patients were analyzed and
compared with the CT images. The GGO percentage on CT
was correlated with the stromal invasion in surgical pathol-
ogy. This study was approved by the hospital’s Institutional
Review Board, and informed consent was obtained from all
patients. A GGO-dominant lesion was defined as a lesion
with a GGO ratio of more than 50%7 on thin-section CT
images, and a pure GGO lesion was defined as a GGO lesion
with no solid part. Lesions with a GGO ratio of less than or
equal to 50%15 were not included in this study.
At our institution, the indications for CT-guided TNB
for small GGO lesions are localized peripheral GGO lesions
persisting for at least 3 months. Such lesions are biopsied
because clinical evidence of whether or not they are malig-
nant can be confirmed and definite treatment implemented.
GGO lesions adjacent to a vessel with a diameter larger than
2 mm were not biopsied because of the concern of major
hemorrhage. CT-guided TNB is technically more difficult for
GGO lesions 4 mm or smaller in size, and therefore such
lesions were also not biopsied and remained under close
observation. All patients were required to discontinue any
anticoagulant therapy at least 5 days before TNB and have a
platelet count of more than 80  103/l and normal pro-
thrombin and activated partial thromboplastin times.
CT-guided TNB was performed using a coaxial tech-
nique with a 19G guiding needle and a 20G spring-loaded
semi-automatic biopsy needle (Temno, Cardinal Health Inc.,
Dublin, OH)22–24 after injecting local anesthesia (2%, lido-
caine). Limited 3 mm and/or 1 mm thin-section images were
used routinely to plan the needle path. Bullae and vessels
were avoided. The guiding needle was aimed at the less
vascular area of the GGO lesion, and a single pleural pene-
tration was performed. The number of tissue cores obtained
depended on the response after each firing. The procedure
was stopped immediately if significant bleeding, hemoptysis,
severe chest pain, or a change in vital signs occurred. Limited
CT images were performed a few minutes after removal of
the biopsy needle. Patients with small asymptomatic pneu-
mothorax, pulmonary hemorrhage, or hemoptysis were
treated conservatively, while symptomatic patients were eval-
uated with serial chest radiographs for the indication of chest
tube placement.22
Image Acquisition and Quantification of GGO
Percentage
All patients had a baseline contrast-enhanced chest CT
study (section thickness 5 mm) within 4 weeks, and addi-
tional 1-mm thin-section CT images using a single-detector
CT (HiSpeed CT/i; GE Healthcare, Milwaukee, WI) or 1.25-mm
thin-section CT images using a 16- or a 64-detector CT
(LightSpeed16 or LightSpeed Volume CT; GE Healthcare).
All patients had 3-mm thin-section CT images taken during
the procedure, and some patients had additional 1-mm thin-
section images.
The quantification of GGO percentage of a pulmonary
lesion was performed using a standard Picture Archive and
Communication System environment using a commercially
available viewer (IMPAX 5.2; Agfa HealthCare N.V., Bel-
gium). To avoid missing volume, summation of the total area
and GGO component of the lesions was performed on con-
tiguous 3-mm thin-section CT images, measured manually by
three radiologists who had 4, 6, and 18 years of experience of
chest CT reading and recorded after they reached a consen-
sus. The GGO percentage of a pulmonary lesion was defined
as the total volume of the GGO component divided by the
total volume of the lesion, which was the summation of all
measured areas in all slices.
Surgery and Pathologic Interpretation
Video-assisted thoracoscopic surgery (VATS) lobec-
tomy and standard lymph node dissection were performed on
all surgical candidates. Intraoperative frozen section analysis
was performed for patients with negative results from CT-
guided TNB. The microscopic evidence of stromal invasion
of all specimens from CT-guided TNB and surgical resection
was reviewed by an experienced pathologist using hematox-
ylin and eosin staining only. BAC can be diagnosed only with
evaluation of the entire tumor. A tumor with any invasive
component is classified as adenocarcinoma (invasive adeno-
carcinoma), regardless of the presence of a BAC compo-
nent.25 Histopathologic evidence of stromal invasion in the
specimens obtained from CT-guided TNB and surgical lo-
bectomy was compared. A positive result from CT-guided
TNB was considered a true positive, and nonspecific benign
results were considered a false negative if surgical resection
revealed malignancy.
Statistical Analysis
All data were analyzed using SAS/STAT software,
version 9.1.3 (SAS Institute Inc., Cary, NC). Continuous data
were expressed as mean  standard deviation. The Student’s
t test was used to compare the means of continuous data,
whereas the 2 test or Fisher’s exact test was used to analyze
categorical data. Logistic regression analysis was used to
analyze the imaging characteristics associated with the pres-
ence of stromal invasion in the pathology. Basic model-fitting
techniques for variable selection, goodness-of-fit assessment,
and regression diagnostics were used in regression analyses
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to ensure the quality of the results. Two-sided p values less
than or equal to 0.05 were considered statistically significant.
RESULTS
Of the 1612 lesions on which CT-guided TNB was
performed, 905 (56.1%) were 3.0 cm or smaller. Fifty-five
patients (44 women, 11 men; age range 44–79 years, mean
61.5  9.0 years) (3.4%) presented with pure GGO (n  30)
or GGO-dominant (n  25) lesions (size range, 0.5–3.9 cm;
1.72  0.73 cm; Table 1). Thirty-nine lesions were less than
or equal to 2 cm and 16 lesions more than 2 cm in diameter.
The majority of the lesions (37/55, 67.3%) were located in the
upper lobes. The number of tissue cores obtained from
CT-guided TNB ranged from one to four. Twenty-six patients
(47.3%) had asymptomatic small pneumothoraces ranging
from 2 to 21 mm in the maximal perpendicular distance
between visceral and parietal pleura. Eleven patients
(20.0%) had self-limited hemoptysis in mild (30 ml; n 
8) and moderate (100 ml; n  3) amounts. All of the 55
patients had minimal or mild parenchymal hemorrhage
along the needle tract or within the lesion. The procedure
was not terminated prematurely in any patient, and no
patient required additional therapy such as a blood trans-
fusion, endotracheal intubation, or chest tube placement
after the biopsy.
The clinical management of the 55 patients with GGO
lesions is shown in Figure 1. Forty-seven patients had ade-
nocarcinomas and 8 had benign or nonspecific findings by
CT-guided TNB. The management for the eight patients with
benign or nonspecific findings was more variable. Close
observation was suggested; however, three patients still pre-
ferred to undergo surgery because of personal anxiety and
the desire to adopt a more aggressive management. In
total, 43 patients (20 pure GGO and 23 GGO dominant)
subsequently received VATS lobectomy and lymph node
dissection (Table 2), with malignant results in all 43
patients including 23 adenocarcinomas with invasive com-
ponents, 19 pure BAC, and 1 mucosa-associated lymphoid
tissue lymphoma (MALToma; Table 2). The final surgical
pathology of the 20 pure GGO lesions included 14 BAC
(cases 1–14) (Table 2; Figure 2) and 6 adenocarcinomas
(cases 15–20) (Figure 3), while the 23 GGO-dominant lesions
included 5 BAC (cases 21–25) (Figure 4), 17 adenocarcino-
mas (cases 2642) (Figure 5), and 1 MALToma (case 43)
(Table 2). The incidence of BAC was significantly higher in
pure GGO lesions (70%, 14/20) compared with GGO-domi-
nant lesions (5/23, 1.7%; p  0.004) (Figure 6).
After CT-guided TNB, 12 patients had nonsurgical
management for pulmonary GGO lesions (Table 3). Among
them, seven patients had biopsy-proven malignancies with
TABLE 1. Demographics and Lesion Characteristics of the
55 Patients with Persistent Ground-Glass Opacity Lesions
Who Underwent CT-Guided Lung Biopsy
Characteristics
Value, Mean  SD
(Range)
Age (yr) 61.5  9.0 (44–79)
Lesion size (cm) 1.72  0.73 (0.5–3.0)
GGO percentage of lesions (%)a
Pure GGO lesion (n  30) 100  0 (100–100)
GGO-dominant lesions (n  25) 84.9  6.6 (72.6–97.0)
Sex, No. (%)
Male 11 (20.0)
Female 44 (80.0)
Location of lesions, No. (%)
Right upper lobe 18 (32.73)
Right middle lobe 3 (5.45)
Right lower lobe 5 (9.09)
Left upper lobe 19 (34.55)
Left lower lobe 10 (18.18)
a Defined as the total area of GGO component divided by the total area of the lesion.
GGO, ground-glass opacity; CT, computed tomography; SD, standard deviation.
FIGURE 1. Flow diagram of pa-
tient management after receiving
CT-guided coaxial TNB. TNB,
transthoracic needle biopsy;
VATS, video-assisted thoracoscopic
surgery; LND, lymph node dissec-
tion; adenoca (inv), adenocarci-
noma with stromal invasion; BAC,
bronchiolar alveolar carcinoma;
MALToma, mucosa-associated lym-
phoid tissue lymphoma; RFA, radio-
frequency ablation of tumor; C/T,
chemotherapy; F/U, follow-up.
*Three false-negative results of CT-
guided core TNB included two BAC
and one MALToma.
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one receiving radiofrequency ablation, four receiving chemo-
therapy, while two were lost to follow-up (Figure 1, Table 3).
Among the five patients with benign or nonspecific results,
two patients (cases 44 and 45) subsequently had stationary
lesions in follow-up chest CT after 2 years and 5 months,
respectively, while the other three patients (cases 46–48)
were lost to follow-up.
In surgical histopathology, all invasive adenocarcino-
mas (n  23) had predominant BAC components. All pure
TABLE 2. Comparison of the Clinical, Radiologic, and Pathologic Results of the 43 Patients
Receiving Both Percutaneous CT-Guided Biopsy and Surgery for Pulmonary GGO Lesions
Case (No.)
GGO
Percentage
CT-Guided Biopsy
Pathology/Presence
of Stromal Invasion
Operative
Pathology
Surgical
Nodal Staging
113 (n  13) Pure GGO Adenocarcinoma/no BAC N0 (n  13)
14 (n  1) Pure GGO No malignancy/— BAC N0 (n  1)
1519 (n  5) Pure GGO Adenocarcinoma/no Adenocarcinoma N0 (n  5)
20 (n  1) Pure GGO Adenocarcinoma/yes Adenocarcinoma N0 (n  1)
2124 (n  4) GGO dominant Adenocarcinoma/no BAC N0 (n  4)
25 (n  1) GGO dominant No malignancy/— BAC N0 (n  1)
2630 (n  5) GGO dominant Adenocarcinoma/no Adenocarcinoma N0 (n  5)
3142 (n  12) GGO dominant Adenocarcinoma/yes Adenocarcinoma N0 (n  11), N2 (n  1)
43 (n  1) GGO dominant Atypical lymphoid infiltration/— MALToma N0 (n  1)
GGO, ground-glass opacity; BAC, bronchioloalveolar carcinoma; MALToma, mucosa-associated lymphoid tissue lymphoma; CT,
computed tomography.
FIGURE 2. A 69-year-old woman was noted to have a
pure GGO lesion in the right middle lobe during low-dose
screening CT. CT-guided coaxial TNB was performed after
a follow-up CT 2 months later showed a stationary size. A,
Thin-section CT showed a localized pure ground glass
nodule. B, Percutaneous CT-guided TNB was performed
with a coaxial needle introduced to the edge of the le-
sion. C, Histopathologic specimen from the core biopsy
(hematoxylin-eosin [HE] stain, 400) showed cuboidal
tumor cells lining the entrapped alveolar space without
evident stromal invasion. D, Photomicrograph of the sur-
gical specimen (HE stain, 400) confirmed BAC with tu-
mor cell proliferation along the alveolar space and lym-
phocyte infiltration in the interstitium.
FIGURE 3. A 70-year-old woman who had a history of thy-
roid papillary carcinoma had a chest CT scan as follow-up,
which showed a pure GGO nodule approximately 2.8 cm in
diameter in the left upper lobe (A) and another smaller GGO
nodule about 7 mm in diameter in the right upper lobe (not
shown). B, Mild focal hemorrhage within the lesion was seen
around the tip of the guiding needle during CT-guided co-
axial TNB. C, Histopathologic specimen from the core biopsy
(hematoxylin-eosin [HE] stain, 400) showed cuboidal tu-
mor cells lining the alveolar space without evident stromal
invasion. D, Photomicrograph of the surgical specimen (HE
stain, 200) turned out to be adenocarcinoma with atypical
glandular structures infiltrating the fibrotic stroma. In this
case, stromal invasion was underestimated in the biopsy
specimen obtained from CT-guided TNB.
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BAC (n  19) had N0 disease, while one of the 23 patients
with invasive adenocarcinoma had N2 disease. Of the 23
invasive adenocarcinomas, stromal invasion was underesti-
mated in 10 patients (cases 15–19, 26–30), including 5 pure
GGO and 5 GGO-dominant lesions, based on the specimens
obtained from CT-guided coaxial TNB (Table 2). Using
surgical pathology as the gold standard, there were three
false-negative cases (cases 14, 25, and 43), including pure
BAC (n  2) and MALToma (n  1) using CT-guided
biopsy (Table 2). The mean lesion size was 1.87 cm for the
three false-negative cases and 2.0 cm for the 10 cases in
which stromal invasion was underestimated. Therefore, we
found that lesion size was not a significant factor affecting the
diagnostic accuracy of TNB. On the basis of the results of
surgical pathology of the 42 lung adenocarcinomas and 1
MALToma, the results of CT-guided core biopsy for GGO
lesions showed an accuracy of 93% (40/43) for malignancy.
Logistic regression analysis was conducted to examine
the relationship between GGO percentage of the pulmonary
lesions and the probability of stromal invasion in surgical
pathology, based on the 42 patients with a surgical diagnosis
of either BAC or adenocarcinoma. Our results showed that
the GGO percentage of a pulmonary lesion was a signifi-
cantly negative predictor of the probability of stromal inva-
sion (p  0.0028; Table 4). The final diagnosis of a pure
FIGURE 6. Comparison of the final histopathologic diagno-
ses between pure GGO and GGO-dominant lesions on CT in
the 43 patients with VATS lobectomy. The chi-square test
was used to analyze categorical proportions of BAC. A p
value 0.05 was considered to be statistically significant.
adenoca (inv), adenocarcinoma with stromal invasion; BAC,
pure bronchioloalveolar carcinoma; MALToma, mucosa-asso-
ciated lymphoid tissue lymphoma.
FIGURE 4. A 73-year-old woman receiving CT for a chronic
cough. It showed a GGO-dominant nodule in the left upper
lobe (A). CT-guided coaxial TNB biopsy was performed. A,
Thin-section CT with 1.25-mm collimation showed a local-
ized GGO-dominant nodule. B, Percutaneous CT-guided
TNB was performed with a coaxial needle introduced into
the middle of the lesion and to the edge of the solid part. C,
Histopathologic specimen from the core biopsy (hematoxylin-
eosin [HE] stain, 200) showed cuboidal tumor cells lining
the entrapped alveolar space without evident stromal inva-
sion. D, Photomicrograph of the surgical specimen (HE stain,
400) confirmed BAC with tumor cell proliferation along
the alveolar space.
FIGURE 5. A 64-year-old woman who had a history of thy-
roid papillary carcinoma underwent a positron emission to-
mography (PET) scan, which showed a hot spot in the left
upper lobe. The lesion slightly increased in size on follow-up
CT 5 months later. A, Thin-section CT with 3-mm collima-
tion showed a 2.2-cm ground glass dominant nodule in the
left upper lobe. B, Percutaneous CT-guided core biopsy was
performed. C, Histopathologic specimen from the core bi-
opsy (hematoxylin-eosin [HE] stain, 400) showed cuboidal
tumor cells lining the alveolar space as well as suspicious tu-
mor invasion into the interstitium. D, Photomicrograph of
the surgical specimen (HE stain, 100) confirmed adenocar-
cinoma with evident stromal invasion.
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GGO lesion on CT was more likely to be a pure BAC, and the
final diagnosis of a GGO-dominant lesion was more likely to
be an adenocarcinoma with predominant BAC component
and some stromal invasion. A conditional effect plot of GGO
percentage of the pulmonary lesion on the probability of
stromal invasion in surgical pathology (Figure 7) based on the
fitted logistic regression model demonstrated a negative cor-
relation between the probability of stromal invasion and GGO
percentage. For example, a GGO percentage of 90% indi-
cated an approximate 75% probability of invasive component
accordingly. The underestimation of stromal invasion was
presumed to decrease if the more solid part of the GGO-
dominant lesion was biopsied under CT guidance, because a
lesser GGO percentage with a greater solid proportion more
likely presented the invasive portion in adenocarcinoma.
DISCUSSION
According to the guidelines of managing small lung
nodules from the Fleischner Society, small GGO lesions
usually require more than 2 years of follow-up.26 However,
malignant GGO nodules can remain stable in size for as long
as 36 months.27 In addition, cancer presenting with pure GGO
nodules may not only increase in size or density but also
decrease in size with the appearance of solid components.28
During the observation period, some malignant tumors will
progress from resectable to unresectable disease.29 Our re-
sults showed that the majority of persistent GGO lesions were
attributable to BAC or invasive adenocarcinoma with a pre-
dominant BAC component, as shown in a previous study.9
For persistent GGO lesions, tissue evidence is warranted due
to the possibility of lung cancer. Because GGO lesions may
not be easy to identify during surgery, VATS resection of
GGO lesions can be performed after lesion localization using
different CT-guided techniques.8,30 Lobectomy for GGO le-
TABLE 3. Comparison of the Clinical, Radiologic, and Pathologic Results of the 12
Patients Receiving Percutaneous CT-Guided Biopsy and Nonsurgical Management for
Pulmonary GGO Lesions
Case (No.)
GGO
Percentage
CT-Guided Biopsy
Pathology/Presence
of Stromal Invasion Nonsurgical Management
44, 45 (n  2) Pure GGO No malignancy/— Follow-up (stationary after 2 yr
and 5 mo, respectively)
4648 (n  3) Pure GGO No malignancy/— No follow-up
49 (n  1) Pure GGO Adenocarcinoma/no RFA
50, 51 (n  2) Pure GGO Adenocarcinoma/no No follow-up
52 (n  1) Pure GGO Adenocarcinoma/yes Chemotherapy
53 (n  1) Pure GGO Adenocarcinoma/no Chemotherapy
54, 55 (n  2) GGO dominant Adenocarcinoma/no Chemotherapy
GGO, ground-glass opacity; RFA, radiofrequency ablation; CT, computed tomography.
TABLE 4. Logistic Regression Analysis of the CT Prediction of the Probability of
Stromal Invasion
Covariate
Parameter
Estimate
Standard
Error
Wald
Chi-Square p
Odds
Ratio
95% Wald
Confidence Limits
Intercept 14.4955 4.8781 8.8301 0.0030 — —
GGO percentage 0.1534 0.0513 8.9285 0.0028 0.858 0.776–0.949
Logistic regression model: n  42, percentage of concordant pairs  69.1%, percentage of discordant pairs  11.7%,
adjusted generalized R2  0.3583, deviance goodness-of-fit test p  0.5016  0.05 (df  21), Pearson goodness-of-fit test
p  0.5390  0.05 (df  21), and Hosmer and Lemeshow goodness-of-fit test p  0.6065  0.05 (df  4).
CT, computed tomography; GGO, ground-glass opacity.
FIGURE 7. Logistic regression analysis was conducted
based on the 42 patients with a surgical diagnosis of either
BAC or adenocarcinoma. A conditional effect plot of GGO
percentage of the pulmonary lesion on probability of stro-
mal invasion in surgical pathology showed a significant neg-
ative correlation between the two parameters (p  0.0028).
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sions and lymph node dissection can be performed after
confirming the histopathologic results from intraoperative
frozen sections if adenocarcinoma is diagnosed.8,30 Unfortu-
nately, interpretation of frozen sections of small GGO lesions
may be difficult and remains challenging.31 It is known that
percutaneous CT-guided core biopsy is an accurate diagnostic
technique for lung lesions,19,20,22,32 but it was not until re-
cently that CT-guided percutaneous TNB was attempted to
diagnose GGO lesions.16–18 Although different patient groups
were enrolled, the accuracy of using coaxial CT-guided core
biopsy for persistent GGO lesions was 93% in our study,
slightly higher than that of using single-shot core biopsy
(91%),17 and much better than CT-fluoroscopy-guided FNA
(82%).18 In this study, there was an increase of procedure-
related complications such as pneumothorax (47.3% versus
38.0%) and pulmonary hemorrhage (100% versus 46.9%)
compared with a previous study using the same technique.22
However, there were no serious complications requiring ad-
ditional management after choosing appropriate candidates.
In our study, only one patient with a GGO-dominant lesion
who underwent surgery showed N2 disease, while all the pure
GGO lesions showed N0 stage. Radiologic findings of GGO,
indicating a BAC component in lung cancer, represent a
positive prognostic factor.10,13,14,33–35 In contrast, nearly 20%
of adenocarcinomas less than 2 cm are node positive if the CT
appearance is not subcategorized.36–39 The prognosis of pure
malignant GGO nodules is excellent,27 and wedge resection
of GGO-dominant tumors has shown favorable results.7,15
Patients with multiple GGO lesions are not infrequently
encountered in our clinical practice. In such patients, percu-
taneous CT-guided coaxial core biopsy targeting one of
multiple GGO lesions plays an important role to avoid more
aggressive diagnostic procedures such as VATS and to decide
the appropriate treatment strategy. In our study, stromal
invasion occurred less commonly in pure GGO lesions and
was more easily underestimated according to histopathology
obtained from CT-guided TNB for pure GGO lesions. We
also found a statistically significant negative correlation be-
tween GGO percentage of a pulmonary lesion and the prob-
ability of stromal invasion in surgical pathology. Our results
suggest that the GGO percentage of a pulmonary nodule
could be used to predict the probability of a BAC component.
This indicates that the solid component in CT image corre-
lates with stromal invasion, which is compatible with the
findings shown in previous studies.11,40,41 Therefore, a core
biopsy for a mixed GGO lesion should be aimed at the solid
part to obtain an appropriate evaluation of stromal invasion.
Fujita et al.42 reported that the 5-year survival rates of groups
with more pathologic invasive signs of stromal invasion were
significantly poorer. Therefore, obtaining the most represen-
tative portion of stromal invasion from CT-guided TNB may
be important for nonsurgical candidates or patients with high
comorbidities who will receive chemotherapy. In addition, it
is equally important for surgical candidates so that the con-
sideration of sublobar resection may not become a risk for
local recurrence.
Our study correlated the GGO percentage on CT and
the probability of stromal invasion. However, we also pro-
pose that in addition to the use of the GGO component as a
morphologic predictor on thin-section CT for stromal tumor
invasion,15 quantitative measurement of the GGO percentage
of a lesion may be useful to predict stromal invasion or pure
BAC. There are several limitations to this study. First, per-
sistent GGO lesions which were not located in the peripheral
lung parenchyma or close to large-sized vessels were not
reachable or too dangerous for CT-guided TNB. Centrally
located or perivascular GGO lesions with a clinical suspicion
of malignancy may be better managed with surgical treat-
ment. Careful selection of appropriate candidates with GGO
lesions for CT-guided TNB is important to avoid serious
complications. Second, the volumetric measurement of GGO
percentage was performed on contiguous 3-mm thin-section
CT images for all cases instead of using 1-mm thin-section
CT images with 10-mm skipped distance. In addition, few
patients did not have 1-mm thin-section images. Therefore,
the measurement was performed on 3-mm thickness to avoid
measurement bias under different scanning thicknesses, al-
though this may not be capable of detecting small proportions
of solid density in small GGO lesions. Third, final patholog-
ical evaluation of stromal invasion may be hindered by
repeated core biopsies and resulting scar formation in the
lesion, especially in smaller lesions. Fourth, the patient num-
ber was small and the incidence of true negative results was
not known, which may require further studies in the future. In
conclusion, after appropriate candidate selection, percutane-
ous coaxial CT-guided biopsy is useful for diagnosing clini-
cally indeterminate pure GGO or GGO-dominant lesions,
with a high diagnostic yield providing useful information for
further patient management.
ACKNOWLEDGMENTS
The authors thank Dr. Fu-Chang Hu, National Center
of Excellence for General Clinical Trial and Research, Na-
tional Taiwan University Hospital and College of Public
Health, National Taiwan University, for his guidance in
regression analysis, and Ms. Chia-Chi Cheng for her assis-
tance in statistical computing.
REFERENCES
1. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer
Action Project: overall design and findings from baseline screening.
Lancet 1999;354:99–105.
2. Webb WR, Müller NL, Naidich DP. Chapter 3: high-resolution com-
puted tomography findings of lung diseases. In WR Webb, NL Mu¨ller,
DP Naidich. (Eds.), High-resolution CT of the Lung. Philadelphia, PA:
Lippincott Williams & Wilkins, 2009. Pp. 118.
3. Zwirewich CV, Vedal S, Miller RR, et al. Solitary pulmonary nodule:
high-resolution CT and radiologic-pathologic correlation. Radiology
1991;179:469–476.
4. Jang HJ, Lee KS, Kwon OJ, et al. Bronchioloalveolar carcinoma: focal
area of ground-glass attenuation at thin-section CT as an early sign.
Radiology 1996;199:485–488.
5. Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure
ground-glass opacity after long-term follow-up of more than 2 years.
Ann Thorac Surg 2002;73:386–392; discussion 392–383.
6. Li F, Sone S, Abe H, et al. Malignant versus benign nodules at CT
screening for lung cancer: comparison of thin-section CT findings.
Radiology 2004;233:793–798.
7. Yoshida J, Nagai K, Yokose T, et al. Limited resection trial for
Journal of Thoracic Oncology • Volume 7, Number 1, January 2012 Percutaneous CT-Guided Coaxial Core Biopsy
Copyright © 2011 by the International Association for the Study of Lung Cancer 149
pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac
Cardiovasc Surg 2005;129:991–996.
8. Ohtsuka T, Watanabe K, Kaji M, et al. A clinicopathological study of
resected pulmonary nodules with focal pure ground-glass opacity. Eur
J Cardiothorac Surg 2006;30:160–163.
9. Kim HY, Shim YM, Lee KS, et al. Persistent pulmonary nodular
ground-glass opacity at thin-section CT: histopathologic comparisons.
Radiology 2007;245:267–275.
10. Kondo T, Yamada K, Noda K, et al. Radiologic-prognostic correlation in
patients with small pulmonary adenocarcinomas. Lung Cancer 2002;36:
49–57.
11. Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass
opacity on high-resolution computed tomography in clinical T1 N0 M0
adenocarcinoma of the lung: a predictor of lymph node metastasis.
J Thorac Cardiovasc Surg 2002;124:278–284.
12. Matsuguma H, Nakahara R, Anraku M, et al. Objective definition and
measurement method of ground-glass opacity for planning limited re-
section in patients with clinical stage IA adenocarcinoma of the lung.
Eur J Cardiothorac Surg 2004;25:1102–1106.
13. Ikeda N, Maeda J, Yashima K, et al. A clinicopathological study of
resected adenocarcinoma 2 cm or less in diameter. Ann Thorac Surg
2004;78:1011–1016.
14. Aoki T, Tomoda Y, Watanabe H, et al. Peripheral lung adenocarcinoma:
correlation of thin-section CT findings with histologic prognostic factors
and survival. Radiology 2001;220:803–809.
15. Nakata M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic
limited resection for ground-glass opacity selected by computed tomog-
raphy. Ann Thorac Surg 2003;75:1601–1605; discussion 1605–1606.
16. Shimizu K, Ikeda N, Tsuboi M, et al. Percutaneous CT-guided fine
needle aspiration for lung cancer smaller than 2 cm and revealed by
ground-glass opacity at CT. Lung Cancer 2006;51:173–179.
17. Kim TJ, Lee JH, Lee CT, et al. Diagnostic accuracy of CT-guided core
biopsy of ground-glass opacity pulmonary lesions. Am J Roentgenol
2008;190:234–239.
18. Hur J, Lee HJ, Nam JE, et al. Diagnostic accuracy of CT fluoroscopy-
guided needle aspiration biopsy of ground-glass opacity pulmonary
lesions. Am J Roentgenol 2009;192:629–634.
19. Klein JS, Salomon G, Stewart EA. Transthoracic needle biopsy with a
coaxially placed 20-gauge automated cutting needle: results in 122
patients. Radiology 1996;198:715–720.
20. Lucidarme O, Howarth N, Finet JF, et al. Intrapulmonary lesions:
percutaneous automated biopsy with a detachable, 18-gauge, coaxial
cutting needle. Radiology 1998;207:759–765.
21. Laurent F, Latrabe V, Vergier B, et al. CT-guided transthoracic needle
biopsy of pulmonary nodules smaller than 20 mm: results with an
automated 20-gauge coaxial cutting needle. Clin Radiol 2000;55:281–
287.
22. Chang YC, Yu CJ, Lee WJ, et al. Imprint cytology improves accuracy of
computed tomography-guided percutaneous transthoracic needle biopsy.
Eur Respir J 2008;31:54–61.
23. Moulton JS, Moore PT. Coaxial percutaneous biopsy technique with
automated biopsy devices: value in improving accuracy and negative
predictive value. Radiology 1993;186:515–522.
24. Chang YC, Wang HC, Yang PC. Usefulness of computed tomography-
guided transthoracic small-bore coaxial core biopsy in the presence of a
pneumothorax. J Thorac Imaging 2003;18:21–26.
25. Colby TV, Noguchi M, Henschke C, et al. Adenocarcinoma. In: Travis
WD, Brambilla E, Muller-Hermelink HK. (Eds.), World Health Orga-
nization Classification of Tumours. Pathology and Genetics of Tumours
of the Lung, Pleura, Thymus, and Heart. Oxford: Lyon: IARC Press,
2004. Pp. 35–40.
26. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management
of small pulmonary nodules detected on CT scans: a statement from the
Fleischner Society. Radiology 2005;237:395–400.
27. Park JH, Lee KS, Kim JH, et al. Malignant pure pulmonary ground-
glass opacity nodules: prognostic implications. Korean J Radiol
2009;10:12–20.
28. Kakinuma R, Ohmatsu H, Kaneko M, et al. Progression of focal pure
ground-glass opacity detected by low-dose helical computed tomogra-
phy screening for lung cancer. J Comput Assist Tomogr 2004;28:17–23.
29. Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with
pulmonary nodules: when is it lung cancer?: ACCP evidence-based
clinical practice guidelines (2nd edition). Chest 2007;132:108S–130S.
30. Mun M, Kohno T. Efficacy of thoracoscopic resection for multifocal
bronchioloalveolar carcinoma showing pure ground-glass opacities of 20
mm or less in diameter. J Thorac Cardiovasc Surg 2007;134:877–882.
31. Marchevsky AM, Changsri C, Gupta I, et al. Frozen section diagnoses of
small pulmonary nodules: accuracy and clinical implications. Ann Tho-
rac Surg 2004;78:1755–1759.
32. Wallace MJ, Krishnamurthy S, Broemeling LD, et al. CT-guided per-
cutaneous fine-needle aspiration biopsy of small ( or 1-cm) pulmo-
nary lesions. Radiology 2002;225:823–828.
33. Kim EA, Johkoh T, Lee KS, et al. Quantification of ground-glass opacity
on high-resolution CT of small peripheral adenocarcinoma of the lung:
pathologic and prognostic implications. Am J Roentgenol 2001;177:
1417–1422.
34. Carretta A, Canneto B, Calori G, et al. Evaluation of radiological and
pathological prognostic factors in surgically-treated patients with bron-
choalveolar carcinoma. Eur J Cardiothorac Surg 2001;20:367–371.
35. Kodama K, Higashiyama M, Yokouchi H, et al. Prognostic value of
ground-glass opacity found in small lung adenocarcinoma on high-
resolution CT scanning. Lung Cancer 2001;33:17–25.
36. Asamura H, Nakayama H, Kondo H, et al. Lymph node involvement,
recurrence, and prognosis in resected small, peripheral, non-small-cell
lung carcinomas: are these carcinomas candidates for video-assisted
lobectomy? J Thorac Cardiovasc Surg 1996;111:1125–1134.
37. Konaka C, Ikeda N, Hiyoshi T, et al. Peripheral non-small cell lung
cancers 2.0 cm or less in diameter: proposed criteria for limited pulmo-
nary resection based upon clinicopathological presentation. Lung Can-
cer 1998;21:185–191.
38. Yoshida J, Nagai K, Yokose T, et al. Primary peripheral lung carcinoma
smaller than 1 cm in diameter. Chest 1998;114:710–712.
39. Kondo D, Yamada K, Kitayama Y, et al. Peripheral lung adenocarcino-
mas: 10 mm or less in diameter. Ann Thorac Surg 2003;76:350–355.
40. Yamada N, Kusumoto M, Maeshima A, et al. Correlation of the solid
part on high-resolution computed tomography with pathological scar in
small lung adenocarcinomas. Jpn J Clin Oncol 2007;37:913–917.
41. Suzuki K, Koike T, Asakawa T, et al. A prospective radiological study
of thin-section computed tomography to predict pathological noninva-
siveness in peripheral clinical IA lung cancer (Japan Clinical Oncology
Group 0201). J Thorac Oncol 2011;6:751–756.
42. Fujita A, Kameda Y, Goya T. Clinicopathology of stromal invasion in
lung adenocarcinoma. Pathol Int 2009;59:1–6.
Lu et al. Journal of Thoracic Oncology • Volume 7, Number 1, January 2012
Copyright © 2011 by the International Association for the Study of Lung Cancer150
